Choline

Form used here: Phosphatidylcholine (PC)

Used for

Cell membrane, liver & neurotransmitter support

Phosphatidylcholine is a phospholipid — a structural building block of every cell membrane in the body — and it's the body's primary dietary source of choline. This ties directly into the cell-membrane-health focus of this whole framework: PC isn't just "a source of choline," it's literally part of the physical structure of the cell membrane itself. Choline is also the direct precursor to acetylcholine, the neurotransmitter responsible for memory formation, attention, and neuromuscular signaling — this is the mechanistic basis for PC's cognitive-support use.

Connects to the homocysteine/methylation cluster too — choline can be oxidized to betaine, which (like the betaine in Methyl-Guard) donates a methyl group in the same homocysteine-recycling pathway. It's not a primary tool there, but it's not unrelated either.

Clinical observation: choline plasmalogen deficiency shows up as a strikingly common finding across testing populations — this is one of the more consistently under-recognized gaps seen in practice, reinforcing phosphatidylcholine's role as foundational cell-membrane support rather than a niche or occasional addition.

Form used here

Phosphatidylcholine, not choline salts

Distinct from choline bitartrate or CDP-choline (citicoline) — PC is the phospholipid-bound form, typically sourced from sunflower or soy lecithin
Because it's structurally a phospholipid rather than a simple choline salt, it integrates directly into cell membranes rather than just raising free choline levels
Also a precursor for acetylcholine, the neurotransmitter involved in memory, attention, and neuromuscular function

Research noteIn non-alcoholic fatty liver disease, 600 mg taken 3x/day for 24 weeks improved liver ultrasound findings consistent with reduced fatty infiltration, though standard liver function blood tests showed more variable results. A large-dose (2.1 g/day) 6-month RCT is registered specifically testing PC added to lifestyle changes for NAFLD. A single 25 g dose improved certain memory measures in a small study of healthy college students — a notably high, acute dose rather than typical daily supplementation. PC has also shown improved remission rates in ulcerative colitis in trial settings.

What the research says

Evidence by outcome

Outcome	Approx. evidence base	Typical finding
Fatty liver (ultrasound findings)	24-week trial, 600 mg 3x/day	Improved liver echogenicity/structure, consistent with reduced fatty infiltration
Liver function blood tests specifically	Same and related trials	More variable/inconsistent results than the imaging findings
Memory (acute, single dose)	Small study, healthy college students	Improvement on certain memory measures after a single 25 g dose
Ulcerative colitis remission	Trial-level evidence	Improved remission rates as an add-on therapy
Acute alcoholic hepatitis (severe disease)	RCT, 6 g/day, 24 months	No significant survival improvement — the benefit doesn't appear to extend to this more severe condition
Plasma triglycerides directly	RCT, 10 people with hypertriglyceridemia	No effect on plasma triglycerides, cholesterol, or VLDL-triglyceride transport
TMAO & cardiovascular risk (mechanistic)	Landmark studies (Nature, NEJM) + >4,000-person cohort	Gut bacteria convert choline/PC into TMAO, which independently predicts cardiac events and promotes atherosclerosis in animal models
TMAO pathway vs. actual dietary choline intake and CVD	Meta-analysis, 6 studies, 184,010 people, 18,076 CVD events	No association found between dietary choline intake and incident cardiovascular disease

The clearest, most consistent signal here is liver-related — imaging improvements in fatty liver specifically. The memory finding is intriguing but comes from a single acute high-dose study, not sustained daily supplementation. And directly on triglycerides: despite the plausible-sounding mechanism (PC is needed to package triglycerides into VLDL for export from the liver), the one human trial that tested it directly found no effect on blood triglycerides at all — the liver-fat benefit and the blood-triglyceride number turned out to be two different things.

On the cardiovascular question specifically: the TMAO research is real and well-replicated at the mechanistic level, and it's reasonable to take seriously. But it's also worth knowing that the largest studies looking at actual dietary choline intake and real-world cardiovascular outcomes haven't found the association the mechanism would predict — likely because how much TMAO any individual produces depends heavily on their specific gut microbiome, not choline intake alone. This is a genuinely unresolved, actively researched question rather than a settled one in either direction.

Research summary chart

View PDF ↗

Dosages used in studies

What the research actually tested

Goal	Typical dose	Notes	Duration
Practitioner-used dose (this site)	~1,000 mg/day	Cell-membrane/general support, below the higher liver-specific research dose	Ongoing, per practitioner
Fatty liver support (research)	1,800 mg/day (600 mg 3x)	The dose with the clearest imaging improvement	24 weeks
Acute memory study (not typical use)	25 g single dose	One-time acute dose, not a daily regimen	Single dose

Safety notes & high-dose risks

What to watch for

The TMAO/cardiovascular question — read this one carefully. Gut bacteria convert choline and phosphatidylcholine into trimethylamine, which the liver then converts to TMAO — a compound that independently predicts cardiac events in large human studies and directly promotes atherosclerosis in animal models. This is legitimate, well-replicated research, not a fringe concern. That said, the largest studies looking at actual dietary choline intake and real-world cardiovascular outcomes have not found a clear association — the risk appears to depend heavily on an individual's specific gut microbiome, not choline intake alone. Worth factoring into decisions for anyone with existing cardiovascular disease or risk factors, discussed directly rather than glossed over.
Generally well tolerated at studied doses, including the higher 1,800 mg/day range used in liver research.
Fishy body odor at very high doses: excess choline can be converted by gut bacteria into a compound that causes a fish-like odor in sweat, breath, and urine in sensitive individuals — a sign to reduce the dose, not a dangerous reaction. (This is a different, more noticeable byproduct of the same gut-bacteria pathway that produces TMAO.)
GI upset (nausea, diarrhea) can occur, particularly starting at higher doses.
Increases acetylcholine — worth a conversation with a prescribing provider for anyone on medications that also affect acetylcholine (certain glaucoma or Alzheimer's medications).

Additional notes

Worth knowing

Not the same as choline bitartrate or CDP-choline — if sourcing this yourself, confirm the label specifically says phosphatidylcholine, since the different forms behave differently in the body.
Sourced from lecithin — typically soy or sunflower; sunflower-derived is the more common choice for anyone avoiding soy.
Timing: take with a meal, consistent with its role in fat digestion and absorption.
Best-supported use is early-stage fatty liver changes — don't extend that evidence to more severe, established liver disease without closer medical supervision.
Retesting: there's no dedicated choline blood test used routinely here — choline plasmalogen status is a separate, specific test. In practice, it's often inferred alongside the omega-3:omega-6 ratio, since a low omega-3 result frequently tracks with low choline plasmalogens as well.

Shop on Fullscript Shop on Prodrome

Educational information only — not medical advice. Lab testing and any supplementation decisions should be made with a qualified healthcare provider who knows your personal health history. Research findings vary by population, dose, form, and study quality.

Some links go to Fullscript, where I may earn a commission at no extra cost to you. I only recommend supplements I've either used myself or seen work in my clients' lab data. Results vary from person to person.